Inventor · Tassin-la-Demi-Lune, FR

Carine Paturel

23Patents
6h-index
25Co-inventors
65Inventor score

Filing activity: Jan 26, 2004 → Jun 30, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US10711063B2 Neutralization of inhibitory pathways in lymphocytes Chemistry; Metallurgy 7 Active
US10676523B2 Treatment regimens using anti-NKG2A antibodies Chemistry; Metallurgy 7 Active
US10246510B2 KIR3DL2 binding agents Physics 7 Active
US9388246B2 TLR3 binding agents Chemistry; Metallurgy 7 Active
US10577419B2 KIR3DL2 binding agents Physics 6 Active
US10870700B2 Neutralization of inhibitory pathways in lymphocytes Chemistry; Metallurgy 6 Active
US10766966B2 CD73 blockade Chemistry; Metallurgy 4 Active
US11377503B2 Antibodies that bind human CD39 and inhibit ATPase activity of a soluble extracellular domain human CD39 polypeptide Chemistry; Metallurgy 3 Active
US11572410B2 Neutralization of inhibitory pathways in lymphocytes Chemistry; Metallurgy 3 Active
US11130817B2 CD73 blocking agents Chemistry; Metallurgy 2 Active
US11858990B2 KIR3DL2 binding agents Physics 2 Active
US10736963B2 Methods for detecting tissue infiltrating NK cells Physics 1 Active
US11377492B2 NKp46 binding agents Chemistry; Metallurgy 1 Active
US11958907B2 CD73 blockade Chemistry; Metallurgy 1 Active
US8273541B2 Compositions and methods for detecting TLR3 Physics 1 Active
US11578136B2 Compositions and methods for treating cancer Chemistry; Metallurgy 1 Active
US9944712B2 TLR3 binding agents Chemistry; Metallurgy 0 Active
US12037392B2 Treatment regimens using anti-NKG2A antibodies Chemistry; Metallurgy 0 Active
US6875580B2 Antibodies specific for plasmacytoid dendritic cells Physics 0 Expired
US8715667B2 Methods of treating patients having TLR3-positive cancer Physics 0 Active
US12202907B2 Nucleic acids encoding and methods of producing proteins comprising antibody chains Chemistry; Metallurgy 0 Active
US12365731B2 NKp46 binding agents Chemistry; Metallurgy 0 Active
US11970535B2 Treatment with anti-KIR3DL2 agents Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.